MDA Advocacy Institute: Briefing on Proposed FDA Reforms

The neuromuscular community has waited long enough for new drugs, and together we have the opportunity to reform the FDA in ways to help speed up the therapy development process. Join us as we discuss these efforts and learn how you can help.